![group of attendees facing the front of a room where a person is speaking](https://www.csl.com/-/media/shared/stock-images/audience-view-speaker.jpg)
CSL's Financial Calendar
Please click the link below to view CSL's current and historic Financial Calendars. Our calendars include dates for all key financial events including; Half Year and Full Year Financial Results, Annual General Meeting (AGM) and Dividends.
Learn MoreSearch Results
176 results found-
CSL also provides other information on its website, including a financial calendar for the 2022/23 financial year, ASX and media announcements, dividend information, presentations and other information for investors.
https://www.csl.com/-/media/shared/documents/one-csl/csl-governance-docs/csl-corporate-governance-statement-2023.pdf -
For example, CSL Behring's 2022 WFH Stewardship Report outlines the following impact (data based on donations received in calendar year 2022, prior to commencement of CSL's new five-year commitment):
https://www.csl.com/-/media/shared/documents/annual-report/csl-annual-report-2023.pdf -
Vifor request consent once per calendar year, not for each activity and for HCPs this has been given at the same time as contracts signed for the initial annual activity undertaken with Vifor.
https://www.csl.com/-/media/shared/documents/vifor-disclosures/methodological-notes/cslviforireland_method_2023_.pdf -
CSL's R&D Awards, Grants and Initiatives
https://www.csl.com/research-and-development/awards-grants-and-initiatives -
ToVs are disclosed on an annual basis and within six months after the end of the calendar year.
https://www.csl.com/-/media/shared/documents/vifor-disclosures/tov/2023_methodologicalnote_switzerland_20240626.pdf -
Notwithstanding a long manufacturing existing products in the core plasma, recombinant and vaccine cycle (typically 9-12 months) we expect the tightness in supply platforms is driven by expanding markets and indications to alleviate throughout the rest of the calendar year.
https://www.csl.com/-/media/one-csl/sustainability/data-and-reporting-centre/documents/csl-limited-tax-transparency-report-2021-22.pdf -
ToVs are disclosed on an annual basis and within six months after the end of the calendar year.
https://www.csl.com/-/media/shared/documents/vifor-disclosures/methodological-notes/methodological-note_2022_ch.pdf -
ToVs are disclosed on an annual basis and within six months after the end of the calendar year.
https://www.csl.com/-/media/shared/documents/vifor/methodological-note-patient-organisations-2021.pdf -
6.1 Time of Publication ToVs are disclosed on an annual basis and within six months after the end of the calendar year.
https://www.csl.com/-/media/shared/documents/vifor-disclosures/methodological-notes/methodological-note-serbia-2021.pdf -
1 Chairman and CEO's Letter 2 CSL Calendar 2 2019 Performance 4 2019 Business performance and highlights 4 14 August Annual profi t and fi nal dividend announcement Financial highlights 5 10 September Shares traded ex-dividend 3 Our Company 6 11 September Record date for fi nal dividend Our businesses 6 Our locations 7 11 October Final dividend paid Our product portfolio 8 16 October Annual General Meeting Our research and development pipeline 9 31 December Half year ends 4 CSL Strategy 10 2020 How we create value 12 12 February Half year profi t and interim dividend 5 Powered by Innovation 14 announcement Collaboration with and funding of medical research 14 11 March Shares traded ex-dividend Investment in research and development pipeline 14 12 March Record date for interim dividend Focus on selected therapeutic areas - specialisation 15 9 April Interim dividend paid New products to market 16 30 June Year ends Clinical trials in process and new 18 19 August Annual profi t and fi nal dividend announcement Clinical trial transparency 18 10 September Shares traded ex-dividend Leveraging advanced analytics and artifi cial intelligence 19 11 September Record date for fi nal dividend Innovation across the value chain 19 9 October Final dividend paid 6 Global Reach and Impact 21 14 October Annual General Meeting Global reach and focus 21 31 December Half year ends Donor management 24 Focus on effi ciency, standardised manufacturing 24 processes and integrated supply chain Annual General Meeting Environment health and safety 25 Wednesday, 16 October 2019 at 1 p.m. Supply chain management 25 7 A Trusted Health Partner 26 New city and venue Product quality and safety 26 Value and access 27 The Westin Sydney, Grand Ballroom Public policy engagement 28 1 Martin Place Secure and reliable supply 29 Sydney NSW 2000 Pandemic and emergency response 29 Relationships with healthcare professionals 29 Share Registry regulators and patient groups Computershare Investor Services Pty Limited Responsible marketing and promotion 29 Postal Address:
https://www.csl.com/-/media/csl/documents/annual-report-docs/csl-ltd-annual-report-2019-full.pdf